(Reuters) - Vivus Inc's obesity drug Qnexa helped people lose weight but may cause long-term health problems in overweight and obese patients, U.S. drugs reviewers said. Food and Drug Administration staff will ask an advisory panel to consider...
Source: http://health.yahoo.net/news/s/nm/vivus-obesity-drug-has-safety-risks-fda-staff
Libya Casey Anthony Pia Toscano Rachel Zoe
No comments:
Post a Comment
Note: only a member of this blog may post a comment.